Pablo Rábano-Suárez1, Laura Bermejo-Guerrero1, Antonio Méndez-Guerrero1, Javier Parra-Serrano1, Daniel Toledo-Alfocea1, Daniel Sánchez-Tejerina1, Teresa Santos-Fernández1, María Dolores Folgueira-López1, Judit Gutiérrez-Gutiérrez1, Blanca Ayuso-García1, Jesús González de la Aleja1, Julián Benito-León2. 1. From the Departments of Neurology (P.R.-S., L.B.-G., A.M.-G., J.P.-S., D.T.-A., D.S.-T., T.S.-F., J.G.d.l.A., J.B.-L.), Microbiology (M.D.F.-L.), Intensive Care Unit (J.G.-G.), and Internal Medicine (B.A.-G.), University Hospital "12 de Octubre"; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) (J.B.-L.); and Department of Medicine (M.D.F.-L., J.B.-L.), Universidad Complutense, Madrid, Spain. 2. From the Departments of Neurology (P.R.-S., L.B.-G., A.M.-G., J.P.-S., D.T.-A., D.S.-T., T.S.-F., J.G.d.l.A., J.B.-L.), Microbiology (M.D.F.-L.), Intensive Care Unit (J.G.-G.), and Internal Medicine (B.A.-G.), University Hospital "12 de Octubre"; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) (J.B.-L.); and Department of Medicine (M.D.F.-L., J.B.-L.), Universidad Complutense, Madrid, Spain. jbenitol67@gmail.com.
Abstract
OBJECTIVE: To report 3 patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who developed generalized myoclonus. METHODS: Patient data were obtained from medical records from the University Hospital "12 de Octubre," Madrid, Spain. RESULTS: Three patients (2 men and 1 woman, aged 63-88 years) presented with mild hypersomnia and generalized myoclonus following the onset of the so-called inflammatory phase of coronavirus disease 2019 (COVID-19). All of them had presented previously with anosmia. Myoclonus was generalized with both positive and negative jerks, predominantly involving the facial, trapezius, sternocleidomastoid, and upper extremities muscles. These myoclonic jerks occurred spontaneously and were extremely sensitive to multisensory stimuli (auditive and tactile) or voluntary movements, with an exaggerated startle response. Other causes of myoclonus were ruled out, and none of the patients had undergone respiratory arrest or significant prolonged hypoxia. All of them improved, at least partially, with immunotherapy. CONCLUSIONS: Our 3 cases highlight the occurrence of myoclonus during the COVID-19 pandemic as a post- or para-infectious immune-mediated disorder. However, we cannot rule out that SARS-CoV-2 may spread transneuronally to first- and second-order structures connected with the olfactory bulb. Further investigation is required to clarify the full clinical spectrum of neurologic symptoms and optimal treatment.
OBJECTIVE: To report 3 patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who developed generalized myoclonus. METHODS: Patient data were obtained from medical records from the University Hospital "12 de Octubre," Madrid, Spain. RESULTS: Three patients (2 men and 1 woman, aged 63-88 years) presented with mild hypersomnia and generalized myoclonus following the onset of the so-called inflammatory phase of coronavirus disease 2019 (COVID-19). All of them had presented previously with anosmia. Myoclonus was generalized with both positive and negative jerks, predominantly involving the facial, trapezius, sternocleidomastoid, and upper extremities muscles. These myoclonic jerks occurred spontaneously and were extremely sensitive to multisensory stimuli (auditive and tactile) or voluntary movements, with an exaggerated startle response. Other causes of myoclonus were ruled out, and none of the patients had undergone respiratory arrest or significant prolonged hypoxia. All of them improved, at least partially, with immunotherapy. CONCLUSIONS: Our 3 cases highlight the occurrence of myoclonus during the COVID-19 pandemic as a post- or para-infectious immune-mediated disorder. However, we cannot rule out that SARS-CoV-2 may spread transneuronally to first- and second-order structures connected with the olfactory bulb. Further investigation is required to clarify the full clinical spectrum of neurologic symptoms and optimal treatment.
Authors: Martijn Beudel; Jan Willem J Elting; Maarten Uyttenboogaart; Mariska W C van den Broek; Marina A J Tijssen Journal: Mov Disord Clin Pract Date: 2014-06-12
Authors: Emmie de Wit; Jurre Y Siegers; Jacqueline M Cronin; Sarah Weatherman; Judith M van den Brand; Lonneke M Leijten; Peter van Run; Lineke Begeman; Henk-Jan van den Ham; Arno C Andeweg; Trenton Bushmaker; Dana P Scott; Greg Saturday; Vincent J Munster; Heinz Feldmann; Debby van Riel Journal: J Infect Dis Date: 2018-03-28 Impact factor: 5.226
Authors: Chiara Tesoriero; Alina Codita; Ming-Dong Zhang; Andrij Cherninsky; Håkan Karlsson; Gigliola Grassi-Zucconi; Giuseppe Bertini; Tibor Harkany; Karl Ljungberg; Peter Liljeström; Tomas G M Hökfelt; Marina Bentivoglio; Krister Kristensson Journal: Proc Natl Acad Sci U S A Date: 2015-12-14 Impact factor: 11.205
Authors: Gianpaolo Toscano; Francesco Palmerini; Sabrina Ravaglia; Luigi Ruiz; Paolo Invernizzi; M Giovanna Cuzzoni; Diego Franciotta; Fausto Baldanti; Rossana Daturi; Paolo Postorino; Anna Cavallini; Giuseppe Micieli Journal: N Engl J Med Date: 2020-04-17 Impact factor: 91.245
Authors: David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri Journal: NPJ Parkinsons Dis Date: 2020-08-20
Authors: Pedro Renato P Brandão; Talyta C Grippe; Danilo A Pereira; Renato P Munhoz; Francisco Cardoso Journal: Tremor Other Hyperkinet Mov (N Y) Date: 2021-07-08
Authors: Neishay Ayub; Joseph Cohen; Jin Jing; Aayushee Jain; Ryan Tesh; Shibani S Mukerji; Sahar F Zafar; M Brandon Westover; Eyal Y Kimchi Journal: Neurohospitalist Date: 2020-12-03
Authors: Afshin A Divani; Sasan Andalib; José Biller; Mario Di Napoli; Narges Moghimi; Clio A Rubinos; Christa O'Hana Nobleza; P N Sylaja; Michel Toledano; Simona Lattanzi; Louise D McCullough; Salvador Cruz-Flores; Michel Torbey; M Reza Azarpazhooh Journal: Curr Neurol Neurosci Rep Date: 2020-10-30 Impact factor: 5.081